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Recent progress harkens back to the old theme of immune memory, except this time in the area of innate immunity, to which 
traditional paradigm only prescribes a rudimentary first-line defense function with no memory. However, both in vitro and in 
vivo studies reveal that innate leukocytes may adopt distinct activation states such as priming, tolerance, and exhaustion, de-
pending upon the history of prior challenges. The dynamic programming and potential memory of innate leukocytes may have 
far-reaching consequences in health and disease. This review aims to provide some salient features of innate programing and 
memory, patho-physiological consequences, underlying mechanisms, and current pressing issues. 
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Mediated by innate pattern recognition-receptors, innate 
immune cells may respond to broad molecular patterns and 
are responsible for the modulation of general immune envi-
ronments, through the expression of diverse inflammatory 
mediators. Unlike the adaptive immune cells that are known 
to adopt distinct memory states toward highly specific anti-
gens, innate immune cells were thought to be highly plastic 
and have no memory of prior challenges. To the contrary, 
data from recent studies increasingly suggest that innate 
immune cells may also be able to adopt “rudimentary” 
memory states under distinct challenge conditions. For ex-
ample, some of the earlier studies suggest that unique com-
binations of cytokine environments may program several 
distinct macrophage phenotypes such as the pro-inflamma- 
tory M1, the anti-inflammatory M2, and various intermedi-
ate subsets (Gordon, 2007; Martinez et al., 2008). Innate 
macrophages and monocytes may also adopt highly dynam-
ic “primed” or “tolerant” state that may correlate with the 
establishment of “non-resolving” vs. “resolving” inflamma-
tion depending on the signal strength and history of prior 
challenges (Morris et al., 2014; Morris, 2015). Clinical ob-
servations support the existence of distinct innate leukocyte 
subsets in vivo, and render the pathophysiological signifi-
cance of innate programming and memory. The non-   
resolving pro-inflammatory macrophages are often corre-
lated with the pathogenesis of inflammatory diseases, and 
the resolving anti-inflammatory macrophages tend to asso-
ciate with tissue repair (Mosser and Edwards, 2008). Here 
we review some of the key features and underlying mecha-
nisms of innate leukocyte programming. 
DISTINCT PROGRAMMING BY DIFFERENT 
CYTOKINE ENVIRONMENTS 
Innate leukocytes such as macrophages have the potential to 
express a large array of cellular mediators including cyto-
kines, chemokines, co-stimulatory molecules, and lipid me-
diators. However, depending upon the nature of the external 
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stimulants, the gene expression profiles of macrophages can  
vary dramatically. Macrophages treated with interferon 
gamma (IFN) are skewed to selectively express pro-   
inflammatory mediators as represented by IL-12 or tumor 
necrosis factor  (TNF, and fail to express anti-     
inflammatory mediators such as IL-10 or TGF. IFN- con-
ditioned macrophages are named as M1 macrophages 
(Gordon and Taylor, 2005). In contrast, the gene expression 
profiles of macrophages treated with IL-4 are drastically 
different, and are represented by the selective expression of 
anti-inflammatory mediators such as arginase 1 (Gordon 
and Taylor, 2005). IL-4 pre-conditioned macrophages are 
also classified as the M2 macrophages. On the other hand, 
immune complexes coupled with lipopolysaccharide (LPS) 
may program macrophages into various M2b subsets with 
selective expression of cell-surface co-stimulatory mole-
cules (Mosser and Edwards, 2008). TGF or IL-10-treated 
macrophages tend to adopt a suppressive phenotype with 
selective expression of IL-10 (Table 1).  
In terms of molecular mechanisms, epigenetic program-
ming through IFN-activated STAT1 may be responsible for 
the global histone acetylation associated with the inflam-
matory gene loci (Qiao et al., 2013). Likewise, IL-4 or 
TGF may induce distinct epigenetic programming events 
in macrophages, leading to the differential skewing of gene 
expression profiles (Lawrence and Natoli, 2011).  
COMBINATORIAL PROGRAMMING WITH 
MULTIPLE IMMUNE STIMULANTS 
Although well-defined and distinct culturing stimulus may 
offer clear differentiation phenotypes of macrophag-
es/monocytes, it may not reflect the complex in vivo envi-
ronment where monocytes may constantly face changing 
landscapes of multiple cellular mediators in a temporal and  
Table 1  Programming dynamics of innate monocytes/macrophagesa) 
Conditions Inducers Effects 
Programming through  
different challenges 
IFN M1 macrophage/ 
monocyte 
IL-4, IL-13 M2a macrophage/ 
monocyte 
ICs+LPS M2b macrophage/ 
monocyte 





β-glucan+LPS Selective training of  
inflammatory monocyte 









Higher dose LPS Transient inflammatory 
and resolving tolerant   
monocyte  
a) ICs, Immune complexes. 
spatial fashion. To address whether monocytes may gain 
potential “memory” from previous challenges, experimental 
systems were designed to provide simultaneous or sequen-
tial challenges to monocytes with multiple distinct stimu- 
lants. For example, monocytes with a prior challenge of 
beta-glucan were “trained” to respond with a more robust 
inflammatory response to a subsequent LPS challenge 
(Netea et al., 2011; Quintin et al., 2012). We reported that 
retinoic acid may synergize with IL-4 in triggering the ex-
pression of M2-type cellular mediators such as arginase 1, 
while co-stimulation of monocytes with IL-4/retinoic acid 
with LPS annihilate the expression of arginase 1 (Surace 
and Li, 2013).  
These phenomenological studies suggest that intra-  
cellular pathways triggered by distinct innate stimulants 
may converge into inter-twined circuits, and responsible for 
the cross-talk within monocytes toward multiple stimulants. 
For example, we and others demonstrated that nuclear re-
ceptors (e.g. RAR, ROR) activated by retinoic acid can 
not only synergize with signal transducer and activator of 
transcription 4 (STAT4) activated by IL-4, but also can po-
tently suppress the inflammatory NFB pathway activated 
by LPS (Huang and Glass, 2010; Maitra et al., 2011).  
Recent mechanistic studies also suggest that the occur-
rence of the “trained immunity” due to the sequential chal-
lenges of distinct stimulants may be the consequence of 
complex alterations at multiple levels such as metabolic 
changes as well as epigenetic modification of chromatin 
structures (Saeed et al., 2014; Cheng et al., 2014). For ex-
ample, beta-glucan “trained” human monocytes may un-
dergo metabolic changes in favor of aerobic glycolysis that 
subsequently causes epigenetic re-programming of selected 
down-stream inflammatory genes (Cheng et al., 2014). 
Likewise, interferon-gamma mediated priming of macro-
phage inflammatory responses may also be due to alteration 
in metabolic pathways, down-regulation of PI3K and 
mTORC1, as well as epigenetic modification of target in-
flammatory genes (Su et al., 2015).  
SIGNAL STRENGTH-DEPENDENT 
PROGRAMMING OF INNATE LEUKOCYTES 
Recent studies from our group and other suggest another 
intriguing aspect of innate immunity programming and 
memory, in that innate leukocytes may not only be able to 
recognize different combinations of extra-cellular stimu-
lants, but also discern their relative signal strength (Baker et 
al., 2014; Deng et al., 2013; Lu et al., 2015; Maitra et al., 
2012; Maitra et al., 2011; Morris et al., 2014). This is re-
flected in the cardinal example of endotoxin priming and 
tolerance. A salient example of selective innate pre-    
conditioning is the paradigm of endotoxin priming and tol-
erance (Morris and Li, 2012). Host monocytes/macrophages 
are the most potent responders to bacterial endotoxin, LPS 
(Gordon, 2007). Most studies regarding cellular responses 
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to LPS utilized higher tolerant dosages of LPS (although 
often referred as “low dose” in the literature) (>10 ng mL1 
in vitro culture, >1 µg mouse1 or > 50 µg kg1 body weight 
in vivo injection). Higher doses LPS cause robust induction 
of pro-inflammatory mediators in monocytes/macrophages 
through the Toll-Like-Receptor 4 (TLR4) pathway (Kawai 
and Akira, 2007). Shortly after the initial wave of expres-
sion, host macrophages develop a state of “endotoxin toler-
ance”, in which the expressions of pro-inflammatory medi-
ators are suppressed (Henricson et al., 1993; Li et al., 2000; 
West and Heagy, 2002). Endotoxin tolerance serves as a 
compensatory mechanism for the resolution of inflamma-
tion (Jacinto et al., 2002; Medvedev et al., 2002). In stark 
contrast, subclinical super-low levels of circulating LPS 
(~1–100 pg mL1) in experimental animals and humans with 
adverse health conditions do not induce compensatory tol-
erance (Hirohashi and Morrison, 1996; Li et al., 2000; 
Sturm, 2002; Zhang and Morrison, 1993). Instead, we and 
others have shown that super-low dose LPS (~1–100     
pg mL1 in vitro, 100 pg–10 ng mouse1 or 5 ng kg1–0.5 µg 
kg1 body weight in vivo injection) “primes” macrophages 
for a more robust response to a secondary LPS challenge in 
vitro and in vivo, a phenomenon known as the “Shwartzman 
reaction” (Deng et al., 2013; Henricson et al., 1993; 
Hirohashi and Morrison, 1996; Zhang and Morrison, 1993) 
(Figure 1).  
One of the critical deficiencies of existing studies re-
garding priming and tolerance is the short time course and 
limited exposure of LPS. Almost all studies employ a single 
LPS challenge to induce priming or tolerance within a 24 h 
time period. We recently tested the hypothesis that repeated 
challenges with super-low dose LPS for a longer period of 
time may polarize monocytes into a low-grade inflammato-
ry state. We observed that repeated challenges with su-
per-low dose LPS indeed establishes a low-grade inflam-
matory monocyte phenotype (ML) in both murine and hu- 
 
 
Figure 1 (color online)  A schematic diagram illustrating the dynamic 
circuitry potentially responsible for the establishment of either low-grade 
non-resolving inflammation or acute resolving inflammation. For the es-
tablishment of acute resolving inflammation, the occurrence of negative 
feedbacks due to the activation of homeostatic modulators such as 
PI3K/AKT, IRAK-M, Tollip, SOCS3, and ERK would be required. On the 
other hand, the clearance of these negative homeostatic modulators would 
favor the low-grade non-resolving inflammation and the establishment of a 
low-grade inflammatory monocyte state (ML). 
man primary monocyte (Yuan et al., 2016).  
Through toll-like-receptor 4 (TLR4), Higher dosages of 
LPS induce transient and resolving inflammation through 
the activation of both classical and alternative NFB path-
ways (O’Neill, 2002; Yoza et al., 2006) The classical NFB 
pathway contributes to the robust yet transient induction of 
pro-inflammatory mediators (Kawai and Akira, 2007). As a 
compensatory mechanism, higher dose LPS also activates 
the anti-inflammatory PI3K pathway that leads to the acti-
vation and induction of several negative regulators such as 
MKP-1, RelB, pAKT, pERK, ROR, and RAR, which 
serve as negative regulators of pro-inflammatory NFB 
function (Chan et al., 2005; Chen et al., 2009a; Chen et al., 
2009b; Li et al., 2009; Piao et al., 2009; Yoza et al., 2006). 
This underlies the phenotype of “endotoxin tolerance” 
(Yoza et al., 2006).  
In stark contrast, the mechanisms for endotoxin priming 
are less well studied and poorly understood. We first re-
ported that super-low dose LPS fails to induce negative reg-
ulators such as nuclear receptors (RAR, ROR, etc), 
PI3K/Akt pathway, ERK, Tollip and RelB in innate leuko-
cytes (Maitra et al., 2011) (Maitra et al., 2012). This may 
explain the lack of tolerance by super-low dose LPS. In-
stead, we observed that super-low dose LPS suppresses 
aforementioned negative regulators and primes monocytes/ 
macrophages for more robust expression of pro-inflamma- 
tory mediators. Among intracellular components of TLR4 
pathway, we reported that IRAK-1 is critical for the effect 
of super-low dose LPS and priming of innate leukocytes 
(Maitra et al., 2012; Maitra et al., 2011). Mechanistically, 
we documented that IRAK-1 is required for suppressor 
clearance induced by super-low dose LPS (Maitra et al., 
2012). In contrast, higher dose LPS activates PI3K and 
leads to IRAK-1 degradation (Li et al., 2000; Noubir et al., 
2004) (Figure 1). 
These studies may explain many previous clinical obser-
vations and bear far-reaching pathophysiological conse-
quences. For example, varying dosages of endotoxin have 
been shown to differentially affect the pathogenesis of 
asthma, atherosclerosis, and sepsis in animal studies (Chen 
et al., 2015; Eisenbarth et al., 2002; Kallio et al., 2008; 
Maitra et al., 2012; Wiesner et al., 2010). Differential de-
velopment of asthma and other inflammatory diseases asso-
ciated with people from developing countries prompted the 
“hygiene theory” that resonates with these dynamic pro-
gramming of innate leukocytes (Vandenbulcke et al., 2006). 
It may be an evolutionary survival advantage for human 
hosts to adopt a compensatory homeostatic tolerance when 
challenged with higher dosages of innate stimulants. On the 
other hand, chronic exposure to minute amount of innate 
stimulants may dispense the tonic homeostatic mechanism 
of tolerance, and develop low-grade wax and wane inflam-
mation. As the chronic inflammation persists, innate leuko-
cytes as well as their hematopoietic precursors may be ex-
hausted, which may contribute to immune exhaustion and 
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“inflammaging” during the aging process (Shaw et al., 
2013).  
The dynamic responses to varying dosages of innate 
stimulants are not limited to endotoxin, and are observed 
with other agonists such as TLR7/8 agonists (Christensen et 
al., 2006; Gorden et al., 2005). This may be a generalized 
phenomenon in innate leukocytes during their dynamic and 
tailored adaption to changing environments over time.  
SYSTEMS BIOLOGY OF INNATE 
PROGRAMING AND MEMORY  
The highly complex and diverse profiles of leukocyte pro-
gramming pose immense challenges for experimental char-
acterization. Recent advances in computational systems 
analyses may offer significant assistance in deciphering 
complex leukocyte dynamics and memory. In collaboration 
with computational biologists, we have identified several 
salient functional motifs required for the establishment of 
priming and homeostatic tolerant states in innate leukocytes. 
For the homeostatic tolerance, the sustained presence of 
robust homeostatic negative regulator(s) would be required 
(Fu et al., 2012; Su J, 2009). This is consistent with experi-
mental observations from our lab and others that reveal the 
induction of multiple negative regulators during the homeo-
static tolerance of innate leukocytes such as Tollip, PI3K, 
ERK, IRAK-M, SOCS3, and IB (Chan et al., 2005; 
Maitra et al., 2012; Piao et al., 2009; Yoza et al., 2006). 
These homeostatic modulators may function at multiple 
levels during the signaling process. On the other hand, for 
the priming process to occur, the pathway switching from 
the induction to the clearance and disruption of negative 
suppressors must occur. Our laboratory has provided data 
confirming the clearance of suppressors such as Tollip and 
IRAK-M, as well as suppression of ERK and PI3K during 
the priming process of innate leukocytes (Baker et al., 2014; 
Deng et al., 2013; Maitra et al., 2012; Maitra and Li, 2013).  
Computational and experimental analyses also converge 
to suggest a dynamic circuit consisting of two mutual-
ly-inhibitory arms of positive and negative regulators, 
which may give rise to the bi-stable states of cellular prim-
ing and homeostatic tolerance (Fu et al., 2012). This salient 
motif may be critically involved in the sensing of rising 
signal strength of innate stimulants, and responsible for the 
fine-tuning of leukocyte functions. Intriguingly, systems 
analyses suggest that this motif may also be at work during 
the dynamic differentiation of T helper cells into distinct 
Th1/Th2/Th17/Treg states (Hong et al., 2012; Hong, 2011), 
and may hold general significance in the modulation im-
mune cells.  
The distinct programming of innate leukocytes may also 
be finely modulated by spatial coordination of signaling 
circuitries. For example, we observed that the Tollip mole-
cule may serve dual roles as both a positive and a negative 
regulator during the activation process of innate leukocytes, 
depending upon its sub-cellular localization. Lysosomal 
Tollip is crucial for maintaining homeostasis by facilitating 
the fusion of lysosome and autophagosome, and the com-
pletion of autophagy (Baker et al., 2015). However, un-
known modification may drive its translocation away from 
lysosome to mitochondria, and switch Tollip from a homeo-
static factor to a stress-promoting molecule (Baker et al., 
2015; Maitra et al., 2012).  
INNATE LEUKOCYTE MEMORY IN 
RESOLVING AND NON-RESOLVING 
INFLAMMATION  
Dynamic modulation and memory of innate immunity may 
have expanding roles in the pathogenesis and resolution of 
inflammatory diseases ranging from acute sepsis to chronic 
diseases such as atherosclerosis, diabetes, impaired wound 
healing, neurological disease and aging. During acute in-
flammatory disease such as acute injury, trauma, acute coli-
tis and sepsis, dysregulated innate immune programming 
may lead to defective host defense toward invasive mi-
crobes, as well as dysregulated tissue inflammation. We 
recently reported that pre-conditioning with super-low dose 
endotoxin pre-disposes animals for increased mortality in 
subsequence sepsis (Chen et al., 2015). Mice pre-     
conditioned with subclinical super-low level of endotoxin 
exhibit severe tissue damage, inflammation, increased bac-
terial load in circulation, and elevated mortality when sub-
jected to cecal-ligation and puncture (CLP). This is in con-
trast to the protective phenomenon with CLP mice 
pre-conditioned with higher tolerant level of LPS. Tolerant 
dosages of LPS skews an anti-inflammatory phenotype in 
both monocyte and neutrophils as reflected in reduced ex-
pression of pro-inflammatory mediators (Chen et al., 2015). 
In contrast, super-low dose LPS polarizes a low-grade 
pro-inflammatory state in monocytes and neutrophils, con-
ducive of tissue damage (Chen et al., 2015). Furthermore, 
we demonstrated that varying dosages of LPS differentially 
modulate the formation of neutrophil extracellular trap 
(NET) in neutrophils. Super-low dose LPS suppresses the 
homeostatic circuits such as PI3K/AKT and ERK that are 
required for the generation of neutrophil NET (Chen et al., 
2015; Kopanakis et al., 2013). In contrast, higher tolerant 
dosages of LPS activates PI3K/ERK and facilitate NET 
formation (Kopanakis et al., 2013). Balancing homeostasis 
in innate leukocytes may hold potential in treating acute 
injury and sepsis. During the chronic inflammatory pro-
cesses, our recent study suggest that polarization of the 
low-grade inflammatory state in innate leukocytes through 
the disruption of homeostatic pathways may similarly play a 
key role in sustaining the non-resolving inflammation that 
underlies the pathogenesis of atherosclerosis, diabetes, de-
layed wound repair, and ageing (Yuan et al., 2016). We 
demonstrated that persistent challenges with super-low dose 
LPS may polarize monocytes into a novel low-grade in-
42 Yuan, R., et al.   Sci China Life Sci   January (2016) Vol.59 No.1 
flammatory state (ML) that is conducive for chronic 
non-resolving inflammation (Yuan et al., 2016). 
Thus, homeostatic resolution of innate leukocyte activa-
tion through the induction of homeostatic molecules, au-
tophagy, and biogenesis of homeostatic organelles such as 
lysosomes may be a viable approach for the treatment of 
both acute and chronic inflammatory disease. To this re-
gard, potential promising compounds such as Tauroursode-
oxycholic Acid (TUDCA) and trehalose have been tested 
and shown to have beneficial effects in maintaining partial 
homeostasis in innate leukocytes and the treatment of in-
flammatory and infectious diseases (Chen et al., 2015; 
Martinez-Lopez et al., 2013; Wu et al., 2015).  
CONCLUSION  
In summary, we are witnessing the emerging concept of 
“innate memory”, and what is known so far only may re-
flect a tip of an iceberg in terms of its complexity and 
translational potential. The continued integration of experi-
mental and computational approaches, coupled with ge-
nomics and proteomics analyses of large datasets, may yield 
rich and exciting profiles of innate leukocyte activation. 
With particular urgency, epigenetic analyses should be per-
formed to define key molecular markers that may assist the 
classification and characterization of novel innate leukocyte 
subsets in health and disease. Translational studies in hu-
mans will help to assign clinical relevance to these emerg-
ing “memory” innate leukocytes in the future.  
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